Protease polymorphisms in HIV-1 subtype CRF01-AE represent selection by antiretroviral therapy and host immune pressure

AIDS

Volumn 24, Issue 3, 2010, Pages 411-416

  Manosuthi, Weerawat ^a,b   Butler, David M ^a   Pérez Santiago, Josué ^a   Poon, Art Fy ^a   Pillai, Satish K ^c   Mehta, Sanjay R ^a   Pacold, Mary E ^a   Richman, Douglas D ^a,d   Pond, Sergei Kosakovsky ^a   Smith, Davey M ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

CRF01 AE; HIV; HLA; Polymorphisms; Protease; Resistance

Indexed keywords

EPITOPE; PROTEINASE; PROTEINASE INHIBITOR;

ALLELE; ANTIVIRAL THERAPY; ARTICLE; ASIAN; BINDING AFFINITY; CONTROLLED STUDY; DATA BASE; DNA POLYMORPHISM; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC DATABASE; HAPLOTYPE; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; VIRUS RESISTANCE;

AMINO ACID SEQUENCE; ANTI-RETROVIRAL AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; DRUG RESISTANCE, VIRAL; HIV INFECTIONS; HIV PROTEASE; HIV-1; HUMANS; MUTATION; POLYMORPHISM, GENETIC;

EID: 75649087356     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283350eef     Document Type: Article

References (26)

1. Hemelaar J, Gouws E, Ghys PD, Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombi-nants in 2004. AIDS 2006; 20:W13-W23.
2. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853-860.
3. Hirsch MS, Gunthard HF, Schapiro JM, Brun-Vezinet F, Clotet B, Hammer SM, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis 2008; 47:266-285.
4. Brumme ZL, Brumme CJ, Heckerman D, Korber BT, Daniels M, Carlson J, et al. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1. PLoS Pathog 2007; 3:e94.
5. Ahlenstiel G, Roomp K, Daumer M, Nattermann J, Vogel M, Rockstroh JK, et al. Selective pressures of HLA genotypes and antiviral therapy on human immunodeficiency virus type 1 sequence mutation at a population level. Clin Vaccine Immunol 2007; 14:1266-1273.
6. Ngumbela KC, Day CL, Mncube Z, Nair K, Ramduth D, Thobakgale C, et al. Targeting of a CD8 T cell env epitope presented by HLA-BM5802 is associated with markers of HIV disease progression and lack of selection pressure. AIDS Res Hum Retroviruses 2008; 24:72-82.
7. Rousseau CM, Daniels MG, Carlson JM, Kadie C, Crawford H, Prendergast A, et al. HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load. J Virol 2008; 82:6434-6446.
8. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, Feeney M, et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004; 10:282-289.
9. Kosakovsky Pond SL, Posada D, Gravenor MB, Woelk CH, Frost SD. GARD: a genetic algorithm for recombination detection. Bioinformatics 2006; 22:3096-3098.
10. Pond SL, Frost SD, Muse SV. HyPhy: hypothesis testing using phylogenies. Bioinformatics 2005; 21:676-679.
11. Rose PP, Korber BT. Detecting hypermutations in viral sequences with an emphasis on G: > A hypermutation. Bio-informatics 2000; 16:400-401.
12. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4:406-425.
13. Tamura K, Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 1993; 10:512-526.
14. Pillai SK, Kosakovsky Pond SL, Woelk CH, Richman DD, Smith DM. Codon volatility does not reflect selective pressure on the HIV-1 genome. Virology 2005; 336:137-143.
15. Grossman Z, Vardinon N, Chemtob D, Alkan ML, Bentwich Z, Burke M, et al. Genotypic variation of HIV-1 reverse transcrip-tase and protease: comparative analysis of clade C and clade B. AIDS 2001; 15:1453-1460.
16. Holguin A, Alvarez A, Soriano V. High prevalence of HIV-1 subtype G and natural polymorphisms at the protease gene among HIV-infected immigrants in Madrid. AIDS 2002; 16:1163-1170.
17. Liu J, Yue J, Wu S, Yan Y. Polymorphisms and drug resistance analysis of HIV-1 CRF01-AE strains circulating in Fujian Province, China. Arch Virol 2007; 152:1799-1805.
18. Holguin A, Sune C, Hamy F, Soriano V, Klimkait T. Natural polymorphisms in the protease gene modulate the replicative capacity of non-B HIV-1 variants in the absence of drug pressure. J Clin Virol 2006; 36:264-271.
19. Ives KJ, Jacobsen H, Galpin SA, Garaev MM, Dorrell L, Mous J, et al. Emergence of resistant variants of HIV in vivo during monotherapy with the proteinase inhibitor saquinavir. J Anti-microb Chemother 1997; 39:771-779.
20. Condra JH, Holder DJ, Schleif WA, Blahy OM, Danovich RM, Gabryelski LJ, et al. Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. J Virol 1996; 70:8270-8276.
21. Ariyoshi K, Matsuda M, Miura H, Tateishi S, Yamada K, Sugiura W. Patterns of point mutations associated with antiretroviral drug treatment failure in CRF01-AE (subtype E) infection differ from subtype B infection. J Acquir Immune Defic Syndr 2003; 33:336-342.
22. Marcelin AG, Flandre P, de Mendoza C, Roquebert B, Peytavin G, Valer L, et al. Clinical validation of saquinavir/ritonavir genotypic resistance score in protease-inhibitor-experienced patients. Antivir Ther 2007; 12:247-252.
23. Johnson VA, Brun-Vezinet F, Clotet B, Gunthard HF, Kuritzkes DR, Pillay D, et al. Update of the drug resistance mutations in HIV-1: Spring 2008. Top HIV Med 2008; 16:62-68.
24. Erickson JW, Burt SK. Structural mechanisms of HIV drug resistance. Annu Rev Pharmacol Toxicol 1996; 36:545-571.
25. John M, Moore CB, James IR, Mallal SA. Interactive selective pressures of HLA-restricted immune responses and antiretro-viral drugs on HIV-1. Antivir Ther 2005; 10:551-555.
26. Shafer RW, Hsu P, Patick AK, Craig C, Brendel V. Identification of biased amino acid substitution patterns in human immunodeficiency virus type 1 isolates from patients treated with protease inhibitors. J Virol 1999; 73:6197-6202.